These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Transplant for TP53-mutated MDS and AML: because we can or because we should? Versluis J; Lindsley RC Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):522-527. PubMed ID: 36485102 [TBL] [Abstract][Full Text] [Related]
11. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndromes are associated with complex karyotype, monosomal karyotype, Wang N; Yuan L; Jing Y; Fan K; Jin H; Lv C; Wang L; Yu L Leuk Lymphoma; 2021 Oct; 62(10):2466-2474. PubMed ID: 33904352 [TBL] [Abstract][Full Text] [Related]
13. TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia. Rahmé R; Braun T; Manfredi JJ; Fenaux P Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189770 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization and prognosis of mutant TP53 acute myeloid leukemia and myelodysplastic syndrome with excess blasts. Shen K; Hu DY; Zhang ZB; Guo YS; Zhang FH; Chen SN Int J Lab Hematol; 2023 Jun; 45(3):344-352. PubMed ID: 36860196 [TBL] [Abstract][Full Text] [Related]
15. TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Marvin-Peek J; Mason EF; Kishtagari A; Jayani RV; Dholaria B; Kim TK; Engelhardt BG; Chen H; Strickland S; Savani B; Ferrell B; Kassim A; Savona M; Mohan S; Byrne M Transplant Cell Ther; 2023 Jun; 29(6):390.e1-390.e10. PubMed ID: 36906277 [TBL] [Abstract][Full Text] [Related]
16. Acute Myeloid Leukemia and Myelodysplastic Syndromes with Sill H; Zebisch A; Haase D Clin Cancer Res; 2020 Oct; 26(20):5304-5309. PubMed ID: 32816950 [TBL] [Abstract][Full Text] [Related]
17. How I Treat Loschi M; Fenaux P; Cluzeau T Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139679 [No Abstract] [Full Text] [Related]
18. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): A unique molecular-cytogenetic subgroup. Hong M; Hao S; Patel KP; Kantarjian HM; Garcia-Manero G; Yin CC; Medeiros LJ; Lin P; Lu X Cancer Genet; 2016 May; 209(5):205-14. PubMed ID: 27134073 [TBL] [Abstract][Full Text] [Related]
19. Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation. Yoshizato T; Nannya Y; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Suzuki H; Nagata Y; Sato Y; Kakiuchi N; Matsuo K; Onizuka M; Kataoka K; Chiba K; Tanaka H; Ueno H; Nakagawa MM; Przychodzen B; Haferlach C; Kern W; Aoki K; Itonaga H; Kanda Y; Sekeres MA; Maciejewski JP; Haferlach T; Miyazaki Y; Horibe K; Sanada M; Miyano S; Makishima H; Ogawa S Blood; 2017 Apr; 129(17):2347-2358. PubMed ID: 28223278 [TBL] [Abstract][Full Text] [Related]
20. A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency. Kato H; Maezawa Y; Nishijima D; Iwamoto E; Takeda J; Kanamori T; Yamaga M; Mishina T; Takeda Y; Izumi S; Hino Y; Nishi H; Ishiko J; Takeuchi M; Kaneko H; Koshizaka M; Mimura N; Kuzuya M; Sakaida E; Takemoto M; Shiraishi Y; Miyano S; Ogawa S; Iwama A; Sanada M; Yokote K Exp Hematol; 2022 May; 109():11-17. PubMed ID: 35240258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]